USA Directory > Science > Biology

  • Chromogranin A
    Chromogranin A / Pancreastatin Cat. # Product Name P01002 Pancreastatin, porcine P01006 Pancreastatin [Tyr0], porcine P01001 Pancreastatin (33-49), porcine P01007 Pancreastatin (33-48) (human) More at info@creative-peptides.com.
    US www.creative-peptides.com/product/chromogranin-a-pancreastatin-14.html
  • MAG 3
    A MAG3 scan is a diagnostic imaging procedure that allows a nuclear medicine physician or a radiologist to visualize the kidneys and learn more about how they are functioning. MAG3 is an acronym for mercapto acetyl tri glycine, a compound that is che
    US www.creative-peptides.com/product/mag-3-item-10-101-187-33672.html
  • Romidepsin
    Romidepsin is a selective inhibitor of histone deacetylase, approved in the US in 2009 for the treatment of cutaneous T-cell lymphoma (CTCL) or/and peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior systemic therapy.
    US www.creative-peptides.com/product/romidepsin-item-10-101-186-33671.html
  • Ubrogepant
    Ubrogepant, also known as MK-1602, is a potent and selective oral calcitonin gene-related peptide (CGRP) receptor antagonist.
    US www.creative-peptides.com/product/cereolysin-item-10-101-178-33664.html
  • Creative Biolabs
    Creative Biolabs Cellrapeutics provides one-stop full CAR T/NK Cell therapy development service, including early non-clinical research, process development, pre-clinical animal model testing, cGMP manufacturing, and phase I-III clinical trials.
    US www.creative-biolabs.com/
  • ADC characterization
    Pharmacokinetics (PK) studies provide critical information regarding the behavior of a drug in circulation and its ultimate form after extensive in vivo metabolism.
    US www.creative-biolabs.com/adc/adc-pharmacokinetics-characterization.htm
  • Car t therapy
    The typical structure of a CAR molecule includes a single chain variable fragment (scFv), a spacer, a transmembrane domain (TM) and an intracellular signaling domain.
    US www.creative-biolabs.com/car-t/cellrapeutics-chimeric-antigen-receptor-car-technology.htm
  • in vivo animal testing
    Taking advantage of the CellRapeutics™ platform, Creative Biolabs provides customized, standardized, reliable and high-quality CAR-T preclinical in vivo assay services for clients across the world.
    US www.creative-biolabs.com/car-t/car-t-preclinical-in-vivo-assay.htm
  • Car t cell evaluation
    At Creative Biolabs, our scientists will professionally perform multiple evaluations on the post-transfection CAR-T cells to verify the solid success of CAR-T construction and superior function. With advanced technologies and experienced researchers.
    US www.creative-biolabs.com/car-t/car-cell-in-vitro-assay-service.htm
  • Car t biomarker
    In a narrow sense of cancer biomarker, it is limited to proteins the most used to challenge in the clinical applications, especially in the CAR-T therapy.
    US www.creative-biolabs.com/car-t/biomarker-identification-selection.htm
  • CD19
    Currently, anti-CD19 CAR-T cell therapies for B-cell malignancies are the most advanced engineered T cell therapies being tested. Clinical trials in ALL and CLL have exhibited robust and striking clinical efficacy.
    US www.creative-biolabs.com/car-t/anti-cd19-car-t-preclinical-in-vivo-assay.htm
  • Vaccine companies
    Well development of a vaccine project requires an experienced partner who understands the unique complexity presented by this important research area.
    US www.creative-biolabs.com/vaccine/vaccine-development-service.htm
  • Vaccination
    Vaccine technology has evolved significantly in the last decade. To accelerate response time to emerging threats, develop vaccines against difficult targets, Creative Biolabs offers a full range of vaccine design and production services.
    US www.creative-biolabs.com/vaccine/
  • RNA vaccine
    Infectious diseases cause an overwhelming number of deaths around the world and their clinical management is often hampered by the emergence of multidrug resistant strains. Therefore, prevention through vaccination is currently the best course of act
    US www.creative-biolabs.com/vaccine/vaccine-technology.htm
  • ADC antibody
    As one major component of an antibody-drug conjugate (ADC), the antibody is the key for target specificity and serves as the cargo to deliver the cytotoxic drug (payload). A payload drug can be attached to different sites on an antibody using diverse
    US www.creative-biolabs.com/adc/antibody-design-and-conjugation.htm
  • Auristatin
    Auristatins are a family of complex analogues to the native antineoplastic product dolastatin 10. They are 100 to 1000 times more toxic than Doxorubicin, a conventional cancer chemotherapy medication.
    US www.creative-biolabs.com/adc/auristatins.htm
  • ADC platform
    ADCs are next-generation precision medicines that target specific surface antigens and fight diseases by delivering cytotoxic payload drugs into the antigen-bearing cells. ADCs are trending in immunotherapy and are believed to have high potential and
    US www.creative-biolabs.com/adc/platform.htm
  • ph sensitive linker
    pH-sensitive linkers (acid-labile linkers), are a class of chemically cleavable linkers that were first used in early ADC developments. Hydrazonesand cis-Aconityl is among the most widely used pH-sensitive linkers. A cis-aconityl linkage is offen use
    US www.creative-biolabs.com/adc/ph-sensitive-linker.htm
  • Disulfide linker
    Disulfides are thermodynamically stable at physiological pH and are designed to release the conjugated payload drug upon internalization into the tumor cells.
    US www.creative-biolabs.com/adc/disulfide-linker.htm
  • Podophyllotoxin
    ADC toxins target crucial intracellular pathways to induce cell death and they can be over 1000-fold more potent than chemo therapeutic agents. Creative Biolabs carriers a large selection of ADC toxins ranging from common auristatins.
    US www.creative-biolabs.com/adc/classify-adc-toxins-6.htm